Global Biobanking Market 2016-2020

2015-11-18
Price :
Published : Nov-2015
No. of Pages : 145

Global Biobanking Market 2016-2020

Covering: This market research report includes a detailed segmentation of the global biobanking market by product type (equipment and consumables) and by sample type (human tissues, stem cells, DNA or RNA, bio-fluids, and others). It also outlines the market shares for key regions such as the Americas, APAC, and EMEA. The key vendors analyzed in this report are Beckman Coulter, BioCision, Taylor-Wharton, Tecan, Thermo Fisher, and VWR.

Market outlook of the global biobanking market

The market research analyst predicts the global biobanking market to grow steadily at a CAGR of approximately 8% during the forecast period. The ability of biobanks to aid in the collection, preparation, processing, handling, recovery, storage, and distribution of tissues and cell samples for therapeutic and research purposes are expected to result in this markets impressive growth rate during the forecast period.

Geographically, the EMEA region is estimated to account for a market share of approximately 44% during the predicted period. The presence of a well-established biobanking system in the Nordic countries, such as Sweden, Norway, Denmark, Finland, and Iceland, is a significant factor that bolsters market growth in this region during the forecast period.

Segmentation by sample type and analysis of the biobanking market

  • Human tissues
  • Stem cells
  • DNA or RNA
  • Bio-fluids
  • Others

According to this market research, the human tissues segment is estimated to account for a market share of approximately 65% during the forecast period. The unavailability of appropriate animal models for some neurological and psychiatric disorders is a critical factor that results in the growing preference for human tissue specimens or samples stored in biobanks.

Product-type segmentation of the biobanking market

  • Equipment
  • Consumables

The market research analysts have predicted the equipment segment to be the largest market segment during the forecast period. The ability of this segment to aid in the storage, handling, maintenance, transport, and tracking of samples and specimens is a noteworthy factor, which results in its impressive market share of more than 74% during the estimated period.

Competitive landscape and key vendors

This market is highly fragmented due to the presence of numerous small and large vendors and is primarily dominated by prominent vendors like Beckman Coulter and Taylor-Wharton. Since the products offered in this market are similar in nature, vendors have to differentiate their services in terms of automation of existing technology and value-added services to gain an edge over their rivals.

The top vendors in this market are -

  • Beckman Coulter
  • BioCision
  • Taylor-Wharton
  • Tecan Group
  • Thermo Fisher Scientific
  • VWR

Other prominent vendors analyzed in this market study are Askion, B&C Group, BioBank, BioCryo, BioRep, BioStorage Technologies, Bluechip, Brooks Life Science Systems, Cryo Bio System, CryoXtract, DNA Genotek, Excilone, Fluidx, Indivumed, LVL Technologies, Micronic, Promega, QIAGEN, RURO, Seralab, SOL Group, Tissue Solutions, Trans-Hit Biomarkers, and Wildcat Laboratory Solutions.

Key questions answered in the report include

  • What will the market size and the growth rate be in 2020
  • What are the key factors driving the global biobanking market
  • What are the key market trends impacting the growth of the global biobanking market
  • What are the challenges to market growth
  • Who are the key vendors in this market space
  • What are the market opportunities and threats faced by the vendors in the global biobanking market
  • What are the trending factors influencing the market shares of the Americas, APAC, and EMEA
  • What are the key outcomes of the five forces analysis of the biobanking market
Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
Publisher : Technavio
More Reports
Title Price Buy Now

EpiCast Report: Growth Hormone Deficiency – Epidemiology Forecast to 2026

EpiCast Report: Growth Hormone Deficiency - Epidemiology Forecast to 2026 Summary GHD is an endocrine disorder characterized by the insufficient production of GH by the pituitary gland (CGF, 2003). The ICD-10 Clinical Modification (ICD-10-CM) code for GHD is E23.0. GHD is more commonly seen in children, although it can develop during adulthood. GHD can be present from birth, in which case it is known as congenital, or it can be secondary due to brain trauma and is known as acquired. The signs and symptoms of the disease can vary. Generally, a child with GHD is born with normal size at birth, but has delayed rates of bone development and bone lengthening later on. GHD in children affects growth and development. In the 7MM, the diagnosed prevalent cases of GHD for all ages and both sexes ......
$3995

EpiCast Report: Venous Thromboembolism – Epidemiology Forecast to 2026

EpiCast Report: Venous Thromboembolism - Epidemiology Forecast to 2026 Summary Venous thromboembolism (VTE), which is composed of deep vein thrombosis (DVT) and pulmonary embolism (PE), is a blood clot (thrombosis) of the circulatory system that leads to impeded blood flow, which can have serious consequences in the affected individual (Heit, 2015). In VTE, a DVT is a clot that occurs only in the veins; generally, they occur in the deep veins of the legs and pelvis, but may also occur in the veins of the upper body (AHA, 2017; Cohen et al., 2007; Heit, 2015). The clot may break off from its original location and travel throughout the circulatory system, and if the clot ends up in the lung, it is known as a PE (AHA, 2017). Our epidemiologists forecast an increase in the diagnosed inciden......
$3995

Chlamydia Tests – Medical Devices Pipeline Assessment, 2017

Chlamydia Tests - Medical Devices Pipeline Assessment, 2017 Summary GlobalData's Medical Devices sector report, "Chlamydia Tests - Medical Devices Pipeline Assessment, 2017" provides an overview of Chlamydia Tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Chlamydia Tests pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team o......
$2500

Partnerships, Licensing, Investments and M&A Deals and Trends for 2016 in Pharmaceuticals

Partnerships, Licensing, Investments and M&A Deals and Trends for 2016 in Pharmaceuticals Summary GlobalData's "Partnerships, Licensing, Investments and M&A Deals and Trends for 2016 in Pharmaceuticals" report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in 2016. The report portrays detailed comparative data on the number of deals and their value in the last five years, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the......
$3500

Top Trends in Healthcare and OTC 2017: Exploring OTC medication, vitamins, minerals and supplements; functional food and drink; and sports nutrition categories

Global consumers are becoming more health-conscious as a reaction to rising obesity levels and lifestyle-related illnesses, such as diabetes, in the modern world. Consumers' busy lives are a major driver for the healthcare and OTC market as people opt for more convenient, multifunctional, and personalized products that better target their specific needs. Over-the-counter (OTC) drugs are those sold directly to a consumer without a prescription from a healthcare professional, as compared to prescription drugs, which may be sold only to consumers possessing a valid prescription. The pressures of modern life are taking their toll on consumers as their increasingly hectic lifestyles, due to work, active social lives and family responsibilities, means that stress is the most concerning hea......
$3450

Partnerships, Licensing, Investments and M&A Deals and Trends for March 2017 in Pharmaceuticals

GlobalData's "Partnerships, Licensing, Investments and M&A Deals and Trends for March 2017 in Pharmaceuticals" report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in March 2017. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry. Data prese......
$1000

Underground Gas Storage Industry Outlook in Europe to 2021: Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Storage Sites

Underground Gas Storage Industry Outlook in Europe to 2021: Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Storage Sites Summary "Underground Gas Storage Industry Outlook in Europe to 2021: Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Storage Sites", is a comprehensive report on underground gas storage industry in Europe. The report provides gas storage site details such as asset name, operator name, storage type, start year, working gas capacity along with withdrawal rate for all active and planned gas storage assets in the region. The report also provides key country comparisons based on contribution to working gas capacity. The report also provides capital expenditure outlook by key countries, year on year, ......
$5000

Underground Gas Storage Industry Outlook in North America to 2021: Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Storage Sites

Underground Gas Storage Industry Outlook in North America to 2021: Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Storage Sites Summary "Underground Gas Storage Industry Outlook in North America to 2021: Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Storage Sites", is a comprehensive report on underground gas storage industry in North America. The report provides gas storage site details such as asset name, operator name, storage type, start year, working gas capacity along with withdrawal rate for all active and planned gas storage assets in the region. The report also provides key country comparisons based on contribution to working gas capacity. The report also provides capital expenditure outlook by key coun......
$5000

Underground Gas Storage Industry Outlook In Former Soviet Union To 2021: Capacity And Capital Expenditure Forecasts With Details Of All Operating And Planned Storage Sites

Underground Gas Storage Industry Outlook In Former Soviet Union To 2021: Capacity And Capital Expenditure Forecasts With Details Of All Operating And Planned Storage Sites Summary "Underground Gas Storage Industry Outlook In Former Soviet Union To 2021: Capacity And Capital Expenditure Forecasts With Details Of All Operating And Planned Storage Sites", is a comprehensive report on underground gas storage industry in Former Soviet Union. The report provides gas storage site details such as asset name, operator name, storage type, start year, working gas capacity along with withdrawal rate for all active and planned gas storage assets in the region. The report also provides key country comparisons based on contribution to working gas capacity. The report also provides capital expenditure o......
$5000

Gas Processing Industry Outlook in Europe to 2021: Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Processing Plants

Gas Processing Industry Outlook in Europe to 2021: Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Processing Plants Summary "Gas Processing Industry Outlook in Europe to 2021: Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Processing Plants", is a comprehensive report on gas processing industry in Europe. The report provides gas processing plant details such as name, operator name, type, start year, process/conditioning methods and gas processing capacity for active and planned gas processing plants in the region. The report also provides key country comparisons based on contribution to processing capacity. The report also provides capital expenditure outlook by key countries, year on year, from 2017 to 2021. Pla......
$5000